Accueil/Actions/CGC

CGC

USD

Canopy Growth Corporation Common Shares

$1.130-0.040 (-3.419%)

Prix en Temps Réel

Healthcare

Drug Manufacturers - Specialty & Generic

Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.170

Haut

$1.180

Bas

$1.100

Volume

16.14M

Fondamentaux de l'Entreprise

Capitalisation Boursière

384.7M

Industrie

Drug Manufacturers - Specialty & Generic

Pays

Canada

Statistiques de Trading

Volume Moyen

25.81M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $0.77Actuel $1.130Haut $5.61

Actualités Connexes

10 nov. 2025 · 12:41

Analyst Upgrades

Benchmark Upgrades Canopy Growth to Hold

Benchmark analyst Mike Hickey upgrades Canopy Growth from Sell to Hold.

Benchmark Upgrades Canopy Growth to Hold

1 nov. 2025 · 12:00

CNBC

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

24 oct. 2025 · 11:00

BusinessWire

Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on